Chemical industry – Page 77

Business
Amgen stacks up additional job cuts

2014-10-28T00:00:00Z

Up to 1100 more staff face redundancy in ongoing restructuring plan
Business
Ineos bets big on shale

2014-10-27T00:00:00Z

UK profit-sharing plan and transatlantic ethane shipping contracts show company’s commitment to a fracking future
Business
Amgen seeks injunction to protect patents

2014-10-23T00:00:00Z

Sanofi and Regeneron sued over cholesterol-regulating antibodies
Business
Agilent to exit NMR

2014-10-23T00:00:00Z

Closure of loss-making ex-Varian business gives users investment dilemma
Business
EPA takes steps to prevent herbicide resistance in weeds

2014-10-22T00:00:00Z

US Agency approves spray for resistant engineered crops, but with restrictions and time limit
Business
Indian manufacturers hit back over quality claims

2014-10-17T00:00:00Z

Study showing drugs exported to Africa are substandard prompts backlash from generic drugmakers
Business
AbbVie backs out of Shire deal

2014-10-17T00:00:00Z

Treasury rule changes make inversion ‘too uncertain’ and remove financial benefits
Business
Bio-based chemicals on the rise in US

2014-10-16T00:00:00Z

Government predicts 10% of chemicals market will be renewable by 2015
Business
Endo outbids QLT for Auxilium merger

2014-10-10T00:00:00Z

Biotech backs out of Canadian deal in favour of increased $2.6bn bid from Endo
Business
EMA finalises trial transparency rules

2014-10-08T00:00:00Z

Researcher access reinstated, but company redaction rights may cause issues
Business
US tax changes ripple into merger deals

2014-10-08T00:00:00Z

Efforts to curb tax-avoiding ‘inversion’ deals will slow, but not stop, the wave
Business
Actavis boosts antibiotics with Durata buyout

2014-10-08T00:00:00Z

$820 million deal gives Actavis control of newly-approved intravenous antibiotic
Business
Becton Dickinson to buy CareFusion for $12bn

2014-10-07T00:00:00Z

Medical devices merger continues consolidation trend
Business
J&J to buy antiviral specialist Alios

2014-10-01T00:00:00Z

$1.75 billion deal brings Phase II compounds for hepatitis C and respiratory syncytial virus
Business
Dow’s $1bn price-fixing fine upheld

2014-10-01T00:00:00Z

Firm loses its appeal against damages for fixing polyurethane prices
Feature
Transparency measures forced on pharma

2014-09-30T00:00:00Z

Previous misdemeanours are compelling the pharmaceutical industry to be more open with financial information and clinical data, writes Nuala Moran
Business
Mitsubishi to buy Japanese gases specialist

2014-09-30T00:00:00Z

Taiyo Nippon Sanso acquisition continues consolidation in Japan’s chemical industry
Business
Lumara splits and sells to AMAG and Perrigo

2014-09-30T00:00:00Z

Lumara has just emerged from bankruptcy and brings a drug for suppressing pre-term birth, plus other women’s health products
Business
Merck KGaA to buy Sigma–Aldrich

2014-09-26T00:00:00Z

$17bn acquisition expands Merck’s life science business and US presence, but it isn’t stepping back from drug development
Business
India backs off drug pricing controls

2014-09-25T00:00:00Z

Current price caps will stand, but rules on how new caps can be imposed are being tightened